Press "Enter" to skip to content

New patent expiration for IPR drug CRESTOR

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for IPR drug CRESTOR

Annual Drug Patent Expirations for CRESTOR
Annual Drug Patent Expirations for CRESTOR

Crestor is a drug marketed by IPR and is included in one NDA. It is available from four suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

CRESTOR drug price trends.

Drug patent litigation for CRESTOR.

The generic ingredient in CRESTOR is rosuvastatin calcium. Four suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for IPR drug CRESTOR
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions